Zhejiang Xianju Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -8.92% vs -2.86% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -34.59% vs -11.69% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "918.30",
          "val2": "1,008.20",
          "chgp": "-8.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "109.00",
          "val2": "216.80",
          "chgp": "-49.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.10",
          "chgp": "600.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "90.40",
          "val2": "138.20",
          "chgp": "-34.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "118.70%",
          "val2": "156.30%",
          "chgp": "-3.76%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -6.17% vs -2.62% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 13.18% vs -28.86% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,734.00",
          "val2": "3,979.60",
          "chgp": "-6.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "640.00",
          "val2": "838.70",
          "chgp": "-23.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.90",
          "val2": "5.80",
          "chgp": "1.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.80",
          "val2": "-0.20",
          "chgp": "-800.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "452.60",
          "val2": "399.90",
          "chgp": "13.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "112.50%",
          "val2": "153.50%",
          "chgp": "-4.10%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

918.30

1,008.20

-8.92%

Operating Profit (PBDIT) excl Other Income

109.00

216.80

-49.72%

Interest

0.70

0.10

600.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

90.40

138.20

-34.59%

Operating Profit Margin (Excl OI)

118.70%

156.30%

-3.76%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -8.92% vs -2.86% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -34.59% vs -11.69% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,734.00

3,979.60

-6.17%

Operating Profit (PBDIT) excl Other Income

640.00

838.70

-23.69%

Interest

5.90

5.80

1.72%

Exceptional Items

-1.80

-0.20

-800.00%

Consolidate Net Profit

452.60

399.90

13.18%

Operating Profit Margin (Excl OI)

112.50%

153.50%

-4.10%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -6.17% vs -2.62% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 13.18% vs -28.86% in Dec 2024

All Annual Results